Research Paper Volume 13, Issue 21 pp 24136—24154

Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort

Association of DDR mutations with survival outcome in MSKCC and TCGA cohorts. (A–B) DDR mutations versus survival outcome with univariate analysis and multivariate regression model in the MSKCC cohort; (C–D) DDR mutations versus survival outcome with univariate analysis and multivariate regression model in the TCGA cohort.

Figure 2. Association of DDR mutations with survival outcome in MSKCC and TCGA cohorts. (AB) DDR mutations versus survival outcome with univariate analysis and multivariate regression model in the MSKCC cohort; (CD) DDR mutations versus survival outcome with univariate analysis and multivariate regression model in the TCGA cohort.